Alumis ALMS
NASDAQ ALMS
$6.82 +0.01 (+0.15%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alumis (ALMS) Price to Sales (2025 - 2026)

Updated

Alumis' Price to Sales came in at 420.75 for Q2 2026.

Analysis

Alumis (ALMS) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Alumis' Price to Sales was 40.21.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Alumis 848.72 Mn -826.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 420.75
Dec 31, 2025 40.19
API Access

Alumis Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALMS&period=max&api_key=YOUR_API_KEY